摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-异丙氧基哌啶 | 43139-18-0

中文名称
4-异丙氧基哌啶
中文别名
——
英文名称
4-isopropoxypiperidine
英文别名
4-propan-2-yloxypiperidine
4-异丙氧基哌啶化学式
CAS
43139-18-0
化学式
C8H17NO
mdl
——
分子量
143.229
InChiKey
RKGXJBAAWCGBQA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    184-186 °C
  • 密度:
    0.90±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933399090

SDS

SDS:480bbdf5ab058b85b8d6236d9c800029
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Isopropoxypiperidine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Isopropoxypiperidine
CAS number: 43139-18-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H17NO
Molecular weight: 143.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    4-异丙氧基哌啶 在 palladium on carbon 、 氢气三乙胺N,N-二异丙基乙胺 作用下, 以 四氢呋喃甲醇乙酸乙酯 为溶剂, 生成 N-[4,6-dimethoxy-2-(4-propan-2-yloxypiperidin-1-yl)pyrimidin-5-yl]-3,3-dimethylbutanamide
    参考文献:
    名称:
    Discovery of a novel Kv7 channel opener as a treatment for epilepsy
    摘要:
    Facilitating activation, or delaying inactivation, of the native Kv7 channel reduces neuronal excitability, which may be beneficial in controlling spontaneous electrical activity during epileptic seizures. In an effort to identify a compound with such properties, the structure-activity relationship (SAR) and in vitro ADME for a series of heterocyclic Kv7.2-7.5 channel openers was explored. PF-05020182 (2) demonstrated suitable properties for further testing in vivo where it dose-dependently decreased the number of animals exhibiting full tonic extension convulsions in response to corneal stimulation in the maximal electroshock (MES) assay. In addition, PF-05020182 (2) significantly inhibited convulsions in the MES assay at doses tested, consistent with in vitro activity measure. The physiochemical properties, in vitro and in vivo activities of PF-05020182 (2) support further development as an adjunctive treatment of refractory epilepsy. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2015.04.074
  • 作为产物:
    描述:
    1-Cbz-4-哌啶酮三乙基硅烷三氟甲磺酸三甲基硅酯 、 palladium 10% on activated carbon 、 氢气 作用下, 以 乙醇二氯甲烷乙酸乙酯 为溶剂, -60.0 ℃ 、137.9 kPa 条件下, 反应 0.5h, 生成 4-异丙氧基哌啶
    参考文献:
    名称:
    取代哌啶基醚的生物催化/还原醚化方法
    摘要:
    已经开发出用于制备高度官能化的哌啶基醚的合成上有用的方案。生物催化还原cyclhexanones的7,10,和14允许用于制备两者的顺式-和反式非对映体具有极高程度的立体化学控制的。相应的三甲基甲硅烷基醚与1-(苄氧羰基)-4-哌啶酮17的还原醚化在三乙基硅烷和催化TMSO-Tf的存在下,以良好或优异的收率提供了所需的哌啶基醚。最终,氮保护基的湿解产生了接近定量产率的哌啶基醚。还介绍了该方法在一系列哌啶醚中的应用,包括二苯基吡咯啉和依巴斯汀的核心骨架。
    DOI:
    10.1016/j.tet.2014.04.064
点击查看最新优质反应信息

文献信息

  • BORON-CONTAINING SMALL MOLECULES
    申请人:Xia Yi
    公开号:US20100256092A1
    公开(公告)日:2010-10-07
    This invention relates to, among other items, 6-substituted benzoxaborole compounds and their use for treating bacterial infections.
    这项发明涉及6-取代苯硼酯化合物等物品,以及它们用于治疗细菌感染的用途。
  • TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF
    申请人:Merck Patent GmbH
    公开号:US20160376283A1
    公开(公告)日:2016-12-29
    The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.
    本发明涉及式I化合物及其药用可接受的组合物,用作TBK/IKKε抑制剂。
  • MK2 INHIBITORS AND USES THEREOF
    申请人:Celgene Avilomics Research, Inc.
    公开号:US20160075720A1
    公开(公告)日:2016-03-17
    The present invention provides compounds, compositions thereof, and methods of using the same.
    本发明提供了化合物、其组合物以及使用它们的方法。
  • PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE
    申请人:Wang Xiaojing
    公开号:US20110251176A1
    公开(公告)日:2011-10-13
    Pyrazol-4-yl-heterocyclyl-carboxamide compounds of Formula I, including stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof, wherein X is a thiazolyl, picolinyl, pyridinyl, or pyrimidinyl, are useful for inhibiting Pim kinase, and for treating disorders such as cancer mediated by Pim kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
    Pyrazol-4-yl-heterocyclyl-carboxamide化合物的化学式I,包括其立体异构体、几何异构体、互变异构体和药学上可接受的盐,其中X是噻唑基、吡啶基、吡啉基或嘧啶基,用于抑制Pim激酶,并用于治疗由Pim激酶介导的癌症等疾病。公开了使用化合物I的方法,用于体外、体内和体内诊断、预防或治疗哺乳动物细胞中的这类疾病,或相关的病理状况。
  • [EN] AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF T790M CONTAINING EGFR MUTANTS<br/>[FR] COMPOSÉS AMINOPYRIMIDINES EN TANT QU'INHIBITEURS DE MUTANTS D'EGFR CONTENANT T790M
    申请人:GENENTECH INC
    公开号:WO2014081718A1
    公开(公告)日:2014-05-30
    This invention relates to novel compounds of formula (I) which are inhibitors of T790M containing EGFR mutants, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the prevention or treatment of cancer. (Formula I)
    这项发明涉及公式(I)的新化合物,这些化合物是T790M含有EGFR突变体的抑制剂,涉及含有它们的药物组合物,它们的制备方法,以及它们在预防或治疗癌症中的应用。
查看更多